Brief: Eton Pharmaceuticals Announces Acquisition Of Pku Golike® For Phenylketonuria

MindMaze Therapeutics Holding SA

22/03/2024 06:03

March 22 (Reuters) - Eton Pharmaceuticals Inc  ETON.O :
    * ETON PHARMACEUTICALS ANNOUNCES ACQUISITION OF PKU GOLIKE®
FOR
PHENYLKETONURIA
    * ETON PHARMACEUTICALS ANNOUNCES ACQUISITION OF PKU GOLIKE®
FOR
PHENYLKETONURIA
    * TRANSACTION IS EXPECTED TO BE ACCRETIVE TO 2024 EARNINGS
    * TRANSACTION IS EXPECTED TO BE ACCRETIVE TO 2024 EARNINGS
    * ESTIMATED PEAK SALES OF MORE THAN $10 MILLION ANNUALLY
    * HAS ALSO BEEN GRANTED A RIGHT OF FIRST NEGOTIATION FOR
RELIEF'S
RLF-OD032 DEVELOPMENT CANDIDATE
    * ETON ALSO RECEIVED U.S. RIGHTS TO RELIEF'S GOLIKE MEDICAL
FORMULAS LINE EXTENSIONS UNDER DEVELOPMENT

Source text for Eikon:  ID:nGNX6F58h8 
Further company coverage:  ETON.O 

 ((Reuters.Briefs@thomsonreuters.com;))